Key Points
- Anna Marrs, a Docusign director, sold 363 shares on Dec. 5 at an average price of $64.50, reducing her stake to 11,525 shares (a 3.05% decline); the transaction was disclosed in an SEC filing.
- The Dec. 5 sale follows two recent disposals by Marrs — 365 shares on Dec. 2 at $68.54 and 728 shares on Sept. 15 at $80.30 — indicating continued insider selling activity.
- DOCU shares were trading down 7.6% (opened at $65.67); the company beat last quarter's estimates (EPS $0.92 vs $0.84, revenue $800.6M, +8.8% YoY) while analysts are mostly cautious with a consensus "Hold" rating and a $86.71 target.
Docusign Inc. (NASDAQ:DOCU - Get Free Report) Director Anna Marrs sold 363 shares of the business's stock in a transaction that occurred on Friday, December 5th. The shares were sold at an average price of $64.50, for a total transaction of $23,413.50. Following the transaction, the director directly owned 11,525 shares of the company's stock, valued at $743,362.50. The trade was a 3.05% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.
Anna Marrs also recently made the following trade(s):
- On Tuesday, December 2nd, Anna Marrs sold 365 shares of Docusign stock. The stock was sold at an average price of $68.54, for a total transaction of $25,017.10.
- On Monday, September 15th, Anna Marrs sold 728 shares of Docusign stock. The stock was sold at an average price of $80.30, for a total transaction of $58,458.40.
Docusign Trading Down 7.6%
Shares of DOCU opened at $65.67 on Friday. The firm has a market cap of $13.21 billion, a PE ratio of 45.92, a P/E/G ratio of 3.53 and a beta of 0.98. The firm has a fifty day simple moving average of $69.48 and a two-hundred day simple moving average of $75.27. Docusign Inc. has a 1-year low of $63.41 and a 1-year high of $107.86.
Docusign (NASDAQ:DOCU - Get Free Report) last released its quarterly earnings results on Thursday, September 4th. The company reported $0.92 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.84 by $0.08. Docusign had a return on equity of 14.98% and a net margin of 9.57%.The firm had revenue of $800.64 million for the quarter, compared to the consensus estimate of $780.35 million. During the same period last year, the business posted $0.97 EPS. The company's revenue for the quarter was up 8.8% on a year-over-year basis. As a group, research analysts forecast that Docusign Inc. will post 1.17 EPS for the current fiscal year.
Institutional Inflows and Outflows
A number of hedge funds have recently made changes to their positions in the stock. Hemington Wealth Management raised its stake in Docusign by 318.1% during the 1st quarter. Hemington Wealth Management now owns 347 shares of the company's stock worth $28,000 after acquiring an additional 264 shares during the period. Banque Transatlantique SA bought a new position in shares of Docusign in the first quarter worth approximately $26,000. Summit Securities Group LLC purchased a new stake in shares of Docusign in the first quarter worth $34,000. Rise Advisors LLC increased its stake in shares of Docusign by 864.6% in the first quarter. Rise Advisors LLC now owns 463 shares of the company's stock worth $38,000 after purchasing an additional 415 shares in the last quarter. Finally, WPG Advisers LLC bought a new stake in shares of Docusign during the 1st quarter valued at $39,000. 77.64% of the stock is currently owned by institutional investors.
Wall Street Analysts Forecast Growth
A number of research analysts have weighed in on DOCU shares. Needham & Company LLC reissued a "hold" rating on shares of Docusign in a report on Friday. UBS Group reduced their price target on shares of Docusign from $85.00 to $75.00 and set a "neutral" rating for the company in a research report on Friday. Bank of America lowered their price objective on shares of Docusign from $102.00 to $82.00 and set a "neutral" rating on the stock in a research note on Friday. Wells Fargo & Company dropped their price objective on shares of Docusign from $85.00 to $75.00 and set an "equal weight" rating on the stock in a report on Friday. Finally, Royal Bank Of Canada reaffirmed a "sector perform" rating and set a $95.00 target price on shares of Docusign in a report on Friday. Four analysts have rated the stock with a Buy rating and sixteen have issued a Hold rating to the company. According to MarketBeat.com, the company presently has an average rating of "Hold" and a consensus target price of $86.71.
Get Our Latest Stock Analysis on DOCU
About Docusign
(
Get Free Report)
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Further Reading
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
